Larvol Delta - 67CuSARTATE-Peptide-Receptor-Radionuclide-Therapy-Administered-to-Pediatric-Patients-With-HighRisk-Relapsed-Refractory-Neuroblastoma

Sartate (67Cu MeCOSar octreotate) - Clarity Pharma

http://clinicaltrials.gov/ct2/show/NCT04023331

Jul 5, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next